Clinical Outcomes of Everolimus With Reduced-Dose Tacrolimus vs Mycophenolate Mofetil With Standard-Dose Tacrolimus in De Novo ABO-Incompatible Kidney Transplant Recipients: 1-Year Follow-up
Clinical Outcomes of Everolimus With Reduced-Dose Tacrolimus vs Mycophenolate Mofetil With Standard-Dose Tacrolimus in De Novo ABO-Incompatible Kidney Transplant Recipients: 1-Year Follow-up
复制标题
依维莫司联合减量他克莫司与吗替麦考酚酯联合标准剂量他克莫司在新 ABO 不相容肾移植受者中的临床结果：1 年随访
DOI：
10.1016/j.transproceed.2021.08.062
复制
发表时间：
2022
影响因子：
0.9
通讯作者：
Uchida Junji
中科院分区：
文献类型：
--
作者：
Kosoku Akihiro;Iwai Tomoaki;Uchida Junji
